Follow RSS for latest reports on this topicCymbalta (Duloxetine) - Market Research and Reports

Major depressive disorder, generalized anxiety disorder, management of diabetic peripheral neuropathic pain and fibromyalgia; management of chronic musculoskeletal pain due to chronic osteoarthritis pain and chronic low back pain.

2012 sales: $4.994 billion

Drug maker: Eli Lilly

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found 5 reports that matched your search.

Refine your search, and find more matches, using the form above.

Depression Drugs Market: By Medication Class (Monoamine Oxidase Inhibitors (MAOIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRI), Anticonvulsants, Beta-Blockers, Benzodiazepines, Others); By Brand (Celexa, Zoloft, Cymbalta, Prozac, Paxil, Others)-Forecast (2016-2021) [Report Updated: 25-02-2016]

Depression is a mood disorder that causes relentless feeling of sadness. Many factors causes depression, including brain biology and chemistry, genetics and life events such as trauma, complicated relationships, childhood experiences, loss of a loved one and any stressful situation.The symptoms of depression are often treated by several types of medications, also known as antidepressant drugs. The...Read More >>>


Published by: Industry ARC

Prices Starting From:

Additional Searches

You may also like to search separately for: Cymbalta (Duloxetine)

We Stock...